Skip to main content
. 2021 Aug 8;13(16):3999. doi: 10.3390/cancers13163999

Figure 5.

Figure 5

Potential taxonomic signatures of therapeutic response in EOC patients receiving neoadjuvant or adjuvant chemotherapy. Differentially represented taxa between platinum-sensitive (i.e., PS) and platinum-resistant (i.e., PR) EOC patients receiving neoadjuvant (A) or adjuvant (B) chemotherapy were identified by linear discriminant analysis (LDA) effect size (LEfSe) analysis. Left, LDA scores; right, cladograms. The logarithmic threshold for discriminative features was set to 2.0. See also Figure S5.